Trial intelligence / Profile preview

Botox for chronic proctalgia

NCT01331356Phase 2Completed

Sponsor
CHU de Nantes
Start
Oct 2010
Primary completion
Jul 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in proctalgia, sponsored by CHU de Nantes. Started Oct 2010; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

proctalgia

Beyond the preview

Go deeper on NCT01331356.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01331356.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call